All news
Primary and Updated Analyses for DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer
17 July 2023Human Epidermal Growth receptor 2 (HER2) is a protein involved in normal cell growth, found in small amounts in almost all human cells, including s...
RWE Research in mCRC
17 July 2023In a recent article published in the Future Oncology, Patient Advocates and DiCE CEO Zorana Maravic explored and enhanced the understanding of the ...
Manifesto for a Healthier Europe
17 July 2023DiCE, together with the EU Health Coalition, urges future EU leaders to prioritise health and life sciences. Ahead of next year’s European el...
EU Commission Approval of Tibsovo® (Ivosidenib) in IDH1-mutated Cholangiocarcinoma
17 July 2023The European Commission approved the use of Tibsovo® (Ivosidenib) as monotherapy for the treatment of locally advanced or metastatic cholangiocarc...
Collaboration with COR2ED – HCC CONNECT
18 June 2023DiCE is pleased to collaborate with HCC CONNECT. HCC CONNECT is an international group of experts in hepatocellular carcinoma (HCC).
...
Liver Cancer Index – Data Gaps
14 June 2023DiCE has started disseminating a survey this spring among clinicians, public health experts, and patient advocates to help to sketch the landscape ...
DiCE at the WECAN Retreat 2023
26 May 2023DiCE attended the Workgroup of European Cancer Patient Advocacy Networks (WECAN) retreat on the 20 and 21 April in Frankfurt (Germany). WECAN is a ...
Join our Young CRC Patient Focus Group
24 May 2023Join DiCE’s focus group & contribute to our mission of raising awareness about the increasing incidence of colorectal cancer in young Eu...
Calling on EU Institutions to Address the Growing Burden of Digestive Cancers
23 May 2023Our CEO, Zorana Maravic, joined United European Gastroenterology (UEG) on 26 April at the European Parliament in Brussels to call for more action t...
Highlights from the EASL Liver Cancer Summit
23 May 2023The European Association for the Study of the Liver (EASL) held the Liver Cancer Summit, its annual conference focused on liver cancer in Estoril, ...
